Clinical Overview
More than half of cerebral infarcts develop some hemorrhagic component at some stage. Most hemorrhagic transformation is petechial hemorrhage (89%); a minority is hematoma (11%). A 2024 series of almost 1400 patients found HI1 to be the most common subtype, followed by HI2 and subarachnoid hemorrhage, while PH2 represented approximately 3%.
Many petechial hemorrhages are asymptomatic. Parenchymal hematomas are the subtype consistently associated with neurological deterioration and worse long-term outcomes.
- Older age and larger stroke size
- Cardioembolic stroke etiology
- Anticoagulant use, thrombolytic therapy, or other recanalization
- Fever, hyperglycemia, and low serum cholesterol
- Elevated systolic blood pressure in the acute setting
After intravenous thrombolysis, predictors include NIHSS >14, proximal MCA occlusion, CT hypodensity affecting more than one-third of the MCA territory, delayed recanalization beyond 6 hours, and absent collateral flow.
Significant hemorrhagic transformation usually manifests as rapid, often profound clinical deterioration. In untreated patients it rarely occurs during the first 6 hours and is usually seen during the first few days, with most cases occurring within 4 days. Following thrombolysis or thrombectomy, most hemorrhage occurs within 24 hours of treatment.
Hemorrhagic transformation is attributed to collateral perfusion of infarcted tissue or reperfusion of tissue containing damaged vessels, with blood extravasation or diapedesis.

